Trademarkia Logo

Canada

C$
EMVOKIR
APPROVED

on 6 Feb 2025

Last Applicant/ Owned by

Boehringer Ingelheim International GmbH

55218 Ingelheim

DE

Serial Number

2238609 filed on 19th Dec 2022

Correspondent Address

MARKS & CLERK

180 Kent StreetSuite 1900Ottawa

ONTARIO

CA

K1P0B6

EMVOKIR

Trademark usage description

pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism, namely, renal diseases, Read More

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism, namely, renal diseases, liver diseases, pancreas diseases, digestive system disorders, gastrointestinal diseases and disorders, obesity; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs, namely, vascular diseases, hematology, blood disorders; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders, musculoskeletal diseases and disorders, central nervous system diseases and disorders, peripheral nervous system diseases and disorders and respiratory system; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues, namely, rashes, sores, psoriasis, eczema; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections, namely, antibiotics, anti-infectives, antivirals; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; pharmaceutical preparations, namely, cell-based immune therapeutics for treatment of cancer, for treatment of immunological diseases, namely, autoimmune diseases and disorders; pharmaceutical preparations, namely, cell based immune therapeutics for treatment of infectious diseases, namely viral infections.


Classification kind code

11

Mark Details


Serial Number

2238609

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 27th Jan 2025
Agent Changed
Submitted for opposition 22
on 29th May 2024
Search Recorded
Submitted for opposition 20
on 29th May 2024
Examiner's First Report
Submitted for opposition 223
on 29th May 2024
Total Provisional Refusal
Submitted for opposition 256
on 11th Dec 2023
Notification of Possible Opposition Sent
Submitted for opposition 257
on 9th Feb 2023
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 8th Feb 2023
Formalized
Submitted for opposition 1
on 8th Feb 2023
Created
Submitted for opposition 228
on 19th Dec 2022
International Registration
Submitted for opposition 30
on 19th Dec 2022
Filed